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Background:  Human  immunodeﬁciency  virus  type  1 (HIV-1)  subtype  B predominates  in Brazil,  but in
the southern  region  subtype  C  is  the  most  frequent,  followed  by  subtypes  B,  F1  and  recombinant  forms.
In  southern  Brazil,  these  subtypes  co-circulate  in subjects  with  homogeneous  demographic  and  clinical
features,  enabling  a better understanding  of  the  role  of  HIV-1  subtypes  on  the  characteristics  of infection.
Objectives:  To  evaluate  the  prevalence  of  different  HIV-1  subtypes  in subjects  with  recent  diagnosis  for
HIV infection  in  the  extreme  south  of  Brazil,  and  to  study  their  association  with  demographic,  behavioral,
clinical  and  laboratorial  characteristics.
Study  design:  We  have  determined  the  genetic  sequence  of  viral  protease  and reverse  transcriptase  (poly-
merase,  connection  and  RNase  H  domains)  isolated  from  studied  subjects.  Viral  subtype  was  inferred  by
comparison  with  reference  HIV  sequences,  and  recombination  was  determined  with  Simplot  analysis.  The
association  of  HIV-1  subtypes  with  studied  characteristics  was  evaluated  by  chi-square,  Fisher’s  exact,
Student’s  t and  Kruskal–Wallis  tests.
Results:  Two  hundred  and  forty-ﬁve  HIV  isolates  were  molecularly  characterized,  and  the  association  with
variables  was  studied  for  233  (95.1%)  patients.  Of those,  46.8%  followed  AIDS  deﬁning  criteria.  HIV-1C
was  responsible  for 56.3%  of  infections,  and  was  associated  with  heterosexual  transmission  (p  = 0.001)
and with  higher  CD4+ T-cell  counts  (p  =  0.02).
Conclusions:  The  molecular  epidemiology  of  HIV-1  in the  southernmost  Brazil  is  currently  steady  with
predominance  of  HIV-1C.  This  is  the  ﬁrst  study  showing  a  robust  association  of  the infection  by  this
l  transubtype  and  heterosexua
. Background
The global distribution of subtypes and circulating recombinant
orms of human immunodeﬁciency virus type 1 (HIV-1) group M
eﬂects the complexity of its molecular epidemiology. HIV-1 sub-
ype C (HIV-1C) is identiﬁed in over 50% of worldwide infections,
nd greatly represented in countries with the largest prevalence of
nfection, such as those of southern Africa, and in highly populated
reas such as India. HIV-1B, accounting for approximately 10% of
he HIV-1 infections, predominates in the Americas and in West-
rn Europe.1 HIV-1B also predominates in Brazil, but subtypes F,
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C and associated recombinant forms co-circulate with expressive
frequency (Fig. 1).2–5 However in the Southern region, a distinct
proﬁle is observed. Currently, depending on the state, 27–79% of
HIV infections are caused by HIV-1C, 23–45% by HIV-1B, 3–29% by
CRF31 BC and other BC recombinants, and HIV-1F and its recombi-
nants account for up to 10% of infections.6–16
Recent studies suggest that the HIV-1 epidemics in Brazil has
initiated with multiple introductions of HIV-1B during the 60s or
70s17,18 in the largest cities of Southeast, and then disseminated
throughout the country. HIV-1F and C had a monophyletic entry in
the country, the former in the Southeast and the latter in the South,
approximately 10–15 years after HIV-1B.18,19 HIV-1F appears to
have originated from Central Africa,18 whereas HIV-1C was likely
Open access under the Elsevier OA license.introduced from East Africa.20–22
The association of heterosexual transmission with non-B HIV
subtypes, and that of men  who have sex with men  and subtype
B has been well characterized. However, such associations were
J. Silveira et al. / Journal of Clinica
Fig. 1. Map  of Brazil depicting the prevalence of the major HIV-1 subtypes and
recombinant forms (CRFs and URFs) in each of the ﬁve macro-regions of the country
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he size of the font in the map. Only HIV-1 forms with signiﬁcant prevalence (above
%) are shown.
ather explained by ethnicity and locale of contamination rather
han by HIV-1 subtypes per se.23,24 In Southern Brazil, where HIV-1B
nd C co-circulate in a homogeneous population, previous studies
y our group11,25 and by others26 have suggested an association
f HIV-1C with heterosexual transmission. More recently, a study
onducted in Florianópolis, Santa Catarina, proved such association
ith conﬁdence,15 but no corroboration has been so far shown in
io Grande do Sul, where HIV-1C likely entered Brazil and where
he highest HIV-1C prevalence occurs.
. Objectives
The present study aimed at evaluating the prevalence of HIV-1
ubtypes and recombinant forms in patients with recent diagno-
is for HIV infection followed up at a HIV/AIDS reference center
n the city of Rio Grande, in the southernmost region of Brazil.
e also studied the association of the HIV subtypes found with
emographic, behavioral, clinical and laboratorial characteristics
etrieved at the moment of inclusion in the study.
. Study design
Study subjects and sample collection: Individuals of age 18 years
r older diagnosed for HIV infection between January 2005 and
ecember 2008 were invited to participate in the study. Subjects
ere enrolled after signing an informed consent. The study has
een approved by the Ethics Committee of the Universidade Federal
e Rio Grande University Hospital under the protocol no. 63/2008.
amples were collected for initial laboratory tests (CD4+ T-cell
ounts and HIV viral load measurements) and for HIV-1 subtype
etermination using plasma samples obtained at HIV diagnosis. An
liquot of plasma was preserved at −80 ◦C for further molecular
nalyses.
Viral RNA extraction, cDNA synthesis and PCR: Viral RNA
xtraction was done with the QIAamp Viral RNA kit (QIAGEN,
hatsworth, USA), according to the manufacturer’s instructions
nd as previously described.13 Nested PCR were conducted to
mplify the virus genomic pol regions of protease (PR), and reversel Virology 54 (2012) 36– 41 37
transcriptase polymerase (RT), connection (CN) and RNase
H (RH) domains. Primers and PCR conditions used were
those described previously for PR and RT,13 For CN and
RH, a fragment of 962 bp containing both regions was
ampliﬁed with a nested PCR using the primers ConX1
(5′tggatgggttatgaact3′) and INT R (5′cagtctacttgtccatgcatggcttc3′)
in the ﬁrst round; and ConX2 (5′atacagaagttagtgggaaaa3′) and
Out3R (5′cattgctctccaattactgtgatatttctcatg3′) in the second round.
When the ampliﬁcation was  not successful, the four genomic
regions were ampliﬁed separately.
Sequence alignments and phylogenetic analyses: PCR products
were sequenced in a 3130XL Genetic Analyzer (Life Technologies,
Carlsbad, USA), and sequences were assembled and edited using
the software SeqMan of DNAStar (DNAStar, Madison, USA) in a
PC/Windows. Edited sequenced were aligned with reference HIV
sequences retrieved from the Los Alamos HIV Database (http://hiv-
web.lanl.gov/) comprising all HIV-1 subtypes. Alignments were
made in ClustalW,27 and further used in phylogenetic inferences
using MEGA 4.128 for HIV-1 subtype assignment. The neighbor-
joining distance method was  used, with Kimura 2-parameter
correction. Phylogenetic cluster conﬁdence was  estimated by
bootstrap (1000 replications). Sequences with discordant phyloge-
netic classiﬁcation in different genomic fragments were subjected
to recombination analysis by bootscanning, available in Simplot
v.3.5.1. Sequences were compared to reference sequences of the
most similar HIV-1 subtypes.
Statistical analyses: Demographical and clinical data of patients
were entered in Excel and then imported into Stata v.9.2. Cohort
descriptive data were studied with averages, standard deviations,
medians and ranges for continuous variables, and absolute and
relative frequencies for categorical variables. We also calculated
absolute and relative frequencies of different HIV-1 subtypes with
their respective 95% conﬁdence intervals. A univariate analysis
was  conducted to evaluate the association of demographic, behav-
ioral, clinical and laboratorial variables with HIV-1 subtypes, using
Chi-square or Fisher’s exact tests. For categorical ordinal vari-
ables, linear trends were evaluated. For continuous variables, the
Student’s t-test was employed, and for those with non-normal
distribution, the Kruskal–Wallis non-parametric test was  used. Dif-
ferences were considered signiﬁcant when p values ≤0.05 were
achieved.
4. Results
Two hundred forty-ﬁve samples from subjects with recent
HIV-1 diagnosis between 2005 and 2008 were successfully
characterized. The association between molecular data with demo-
graphical and clinical data was conducted for 233 (95.1%) cases.
The year distribution of HIV diagnoses was: 44 (18.9%) in 2005,
66 (28.3%) in 2006, 70 (30%) in 2007 and 53 (22.8%) in 2008. One
hundred twenty-nine subjects (55.4%) were male, with a male-to-
female (M:F) ratio of 1.24:1. Additional demographical and clinical
data of the patients studied and their relation with gender are
shown in Table 1. A difference in the median CD4+ T-cell counts
between males and females was  initially observed. However, when
the 22 pregnant women (9.4% of the total sample and 21.1% of
females) present in the cohort were excluded from the analysis, the
median CD4+ T-cell counts in females decreased to 324 cells/mm3,
and the signiﬁcance of the difference from males was lost (p = 0.1;
data not shown).
Of the 245 HIV-1 isolates studied, we  obtained sequence data of
PR for 141 (57.6%) and of RT polymerase domain for 87 (35.5%).
For the C-terminal RT domains, we  analyzed 164 (66.9%) sam-
ples for CN, and 168 (68.6%) for RH. As seen, the entire pol gene
was  not obtained for all viruses, but the fragments analyzed were
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Table  1
Demographic, behavioral, clinical and laboratorial characteristics of the studied population, and their distribution according to gender, HU/FURG, Rio Grande, 2005–2008
(n  = 233).
Characteristic Total 233 n (%) Female 104 n (%) Male 129 n (%) p
Age group
18–24 44 (18.9) 30 (28.9) 14 (10.8) 0.006
25–34  73 (31.3) 28 (26.9) 45 (34.9)
35–49  88 (37.8) 36 (34.6) 52 (40.3)
≥50  28 (12.0) 10 (9.6) 18 (14.0)
Transmission route (n = 212)*
Heterosexual 162 (76.4) 92 (95.9) 70 (60.3) 0.001
Homosexual 25 (11.8) 0 25 (21.6)
IDU  24 (11.3) 3 (3.1) 21 (18.1)
Other  1 (0.5) 1 (1.0) 0
HIV+ partner 52 (22.4) 30 (28.9) 22 (17.1) 0.032
Partner  on ARV (n = 218)* 10 (4.3) 7 (7.5) 3 (2.4) 0.079
AIDS  diagnosis** 109 (46.8) 39 (37.5) 70 (54.3) 0.01
CDC  clinical category
A 127 (54.5) 68 (65.4) 59 (45.7) 0.008
B  27 (11.6) 11 (10.6) 16 (12.4)
C 79 (33.9) 25 (24.0) 54 (41.9)
CDC  immunological category***
1 62 (26.6) 35 (33.6) 27 (20.9) 0.051
2  83 (35.6) 37 (35.6) 46 (35.7)
3  88 (37.8) 32 (30.8) 56 (43.4)
HCV+ (n = 225)*,a 20 (8.9) 7 (6.9) 13 (10.6) 0.3
Tuberculosis (n = 231)*,a 34 (14.7) 8 (7.7) 26 (20.5) 0.006
Death  in the 1st year 26 (11.2) 11 (10.6) 15 (11.6) 0.8
Median (IQR)
CD4+ T-cell counts 317 (104–520) 367 (138–578) 247 (71–465) 0.01****
Plasma HIV viral load (cp/mL) 30,693 (8638–131,007) 18,920 (4666–105,194) 42,464 (11,777–141,990) 0.007****
IDU, intravenous drug user.
a At the date of HIV diagnosis.
* Number of cases for which the variable was available.
** CDC 1993 criteria.
*** CDC 1993 criteria – 1, ≥500/mm3; 2, between 499 and 200/mm3; 3, ≤199/mm3.
**** Kruskal–Wallis test.
Table 2
HIV-1 subtype distribution according to demographic and behavioral characteristics studied, HU/FURG, Rio Grande, 2005–2008 (n = 233).
Characteristic Subtype B 49 n (%) Subtype C 131 n (%) Subtype F1 13 n (%) Recombinants 40 n (%) p
Gender
Female 19 (38.8) 63 (48.1) 5 (38.5) 17 (42.5) 0.6
Male  30 (61.2) 68 (51.9) 8 (61.5) 23 (57.5)
Age  group
18–24 8 (16.4) 26 (19.8) 1 (7.7) 9 (22.5) 0.1
25–34  10 (20.4) 48 (36.7) 7 (53.8) 8 (20.0)
35–49  25 (51.0) 43 (32.8) 3 (23.1) 17 (42.5)
≥50  6 (12.2) 14 (10.7) 2 (15.4) 6 (15.0)
Place  of residence
Rio Grande/Pelotas 43 (87.8) 120 (91.6) 10 (76.9) 36 (90.0) 0.3
Uruguay border 6 (12.2) 11 (8.4) 3 (23.1) 4 (10.0)
Transmission route (n = 212)*
Heterosexual 27 (61.4) 100 (83.3) 9 (69.2) 26 (74.3) 0.001
Homosexual 14 (31.8) 5 (4.2) 2 (15.4) 4 (11.4)
IDU 3  (6.8) 15 (12.5) 2 (15.4) 5 (14.3)
HIV+ partner 11 (22.4) 31 (23.7) 3 (23.1) 7 (17.5) 0.8
AIDS  diagnosis** 23 (46.9) 57 (43.5) 6 (46.2) 23 (57.5) 0.4
CDC  clinical category
A 25 (51.0) 75 (57.2) 9 (70.0) 18 (45.0) 0.4
B 9 (18.4)  12 (9.2) 1 (7.7) 5 (12.5)
C  15 (30.6) 44 (33.6) 3 (2.3) 17 (42.5)
CDC  immunological category***
1 12 (24.5) 38 (29.0) 4 (30.8) 8 (20.0) 0.7
2  17 (34.7) 49 (37.4) 4 (30.8) 13 (32.5)
3  20 (40.8) 44 (33.6) 5 (38.4) 19 (47.5)
Death  in the 1st year 8 (16.3) 12 (9.2) 0 6 (15.0) 0.2
Median (IQR)
CD4+ T-cell counts 263 (64–465) 350 (136–540) 326 (72–635) 235 (58–441) 0.1****
Plasma HIV viral load (cp/mL) 48,114 (10,634–113,755) 24,141 (6183–127,721) 45,508 (19,716–101,710) 30,280 (12,081–157,391) 0.5****
IDU, intravenous drug user.
* Number of cases for which the variable was available.
** CDC 1993 criteria.
*** CDC 1993 criteria – 1, ≥500/mm3; 2, between 499 and 200/mm3; 3, ≤199/mm3.
**** Kruskal–Wallis test.
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ufﬁcient to classify all of them phylogenetically. The conjoint anal-
sis of these genomic fragments showed that 51 (20.8%; 95% CI
5.7–25.9) were subtype B viruses, 138 (56.3%; 95% CI 50.1–62.6)
ere subtype C, 13 (5.3%; 95% CI 2.5–8.1) were subtype F and 43
17.6%; 95% CI 12.7–22.3) were recombinant forms (Fig. 2A). The
revalence of HIV-1 subtypes remained constant over the period
tudied, predominated by subtype C (Fig. 2B). In the 12 samples
or which no clinical data was studied (see above), the relative fre-
uencies of HIV-1 subtypes were similar to the casuistic analyzed
not shown).
The phylogenetic analysis of the recombinant forms found evi-
enced one CRF31 BC and one CRF28/29 BF. For the latter, the
ragment analyzed did not allow the discrimination of the two CRFs
28 BF or 29 BF), as these two have the same ancestral origin for
he region analyzed. The remaining 41 recombinant forms were
ll unique (URFs): 26 B/C, 7 B/F, one B/F/C and 7 CRF12 BF-derived
ecombinants (data not shown).
When demographic and behavioral characteristics were com-
ared between viral subtypes, a signiﬁcant association was
bserved between the reported route of HIV acquisition and infect-
ng subtype. Heterosexual transmission was more prevalent among
ubtype C-infected subjects (61.7%), whereas MSM  predominated
mong subtype B-infected subjects (56%) (p = 0.001). The remain-
ng demographic, behavioral and clinical characteristics studiedl Virology 54 (2012) 36– 41 39
did not show differences between infecting subtypes (Table 2).
With respect to geographic origin, subjects from the border with
Uruguay also showed higher prevalence of HIV-1C (Table 2), and
none of the 7 isolates harboring CRF12 BF-derived genomic frag-
ments belonged to patients originated from that locale.
Since HIV-1C represented the majority of strains in our casuis-
tic, data were grouped for subtype C and non-subtype C-infected
subjects. Comparison of these groups revealed that the association
between HIV-1C infection and heterosexual transmission remained
signiﬁcant (p = 0.001). In addition, a difference in CD4+ T-cell counts
at study entry was found between the two groups, with subjects in
the subtype C group presenting a median of 350 cells/mm3 (IQR 16-
540) and the non-subtype C a median of 246 (IQR 64-489) (p = 0.02,
Kruskal–Wallis test). We  have also adjusted the distribution of HIV-
1 subtypes (C or non-C) for gender and age categories. None of
the correlations were statistically signiﬁcant, with the exception
of the age group between 18 and 24 years, in which subtype C was
correlated with women and non-C with men.
5. Discussion
The recently diagnosed HIV-1+ subjects were composed of 55.4%
of men  and 44.6% of women and had an average age of 36 years.
The M:F  ratio of 1.24:1 and the predominance of heterosexual
transmission, responsible for 76.4% of cases, are compatible with
the current epidemiological scenario of HIV infection in Brazil
(http://www.aids.gov.br).
An important observation corroborated by this study is that
despite the success of the Brazilian AIDS Program in AIDS pre-
vention and treatment, HIV diagnosis is late in a signiﬁcant part
of the infected subjects. In this study, 37.5% of the subjects pre-
sented levels of CD4+ T-cell counts below 200 cells/mm3, and 54.9%
of them had counts below 350 cells/mm3, evidencing a signiﬁcant
proportion of lately diagnosed subjects according to the Brazilian
guidelines.
The molecular epidemiology results of this study corroborate
previous reports from southern Brazil, showing the predom-
inance of HIV-1C, followed by HIV-1B, and lastly by other
forms.6,7,11,12,14,15,25,29 CRF31 BC, described by our group in 2006,29
was  rarely found here. Among the 27 B/C recombinant viruses
observed, only one harbored recombination breakpoints compat-
ible with CRF31 BC. This is consistent with reports showing that
the growth rate of CRF31 BC is lower than that of HIV-1C.11,18
Moreover, despite the fact that the prevalence of CRF31 BC strains
increased from 9% in 2002 to 25% in 2004 in Porto Alegre,11 in Rio
Grande and in Itajaí, SC, cities with similar socio-demographic and
cultural characteristics, the prevalence of this CRF remained below
4% in the same period.6,11
We  were not able to PCR amplify the entire pol gene from all
viruses. Since the cohort analyzed here was  of consecutive enroll-
ment, irrespective of HIV VL at the time of collection, some subjects
had low (<1000 copies) VL, which could at least in part explain
the failures of the ampliﬁcations observed. Moreover, the high
genetic diversity observed, with multiple subtypes and recombi-
nants, could also impair primer annealing and consequently PCR
efﬁciency. However, the congruence between the subtype distri-
bution seen herein and that previously reported in southern Brazil
validates our results.
An important proportion of HIV+ subjects residing in the bor-
dering cities to Uruguay (45%) were infected with HIV-1C. This is
the ﬁrst report showing such a relevant circulation of this subtype
in the area. Previous research conducted in Argentina, Uruguay and
Paraguay showed only marginal circulation of HIV-1C, with preva-
lence rates below 1%.30–33 Conversely, seven different viral isolates
harboring CRF12 BF-derived fragments were found inwards of the
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order to Uruguay, an observation not previously reported in the
egion.10 The identiﬁcation of this CRF in inland Brazil shows the
hanging dynamics of the circulation of HIV-1 strains, which war-
ants periodic molecular surveillance.
The lack of signiﬁcant associations between infecting HIV-1 sub-
ypes and gender, age groups, locale of residence, HIV+ partners,
nd clinical characteristics in this casuistic is relevant and shows
he homogeneity of the cohort studied. The association between the
ransmission route and viral subtypes is therefore paramount. Het-
rosexual transmission was more prevalent in HIV-1C, whereas the
omosexual route was more frequent in HIV-1B. The signiﬁcance
as maintained when we  grouped all non-C viruses compared to
IV-1C, the most frequent in our casuistic. Despite several previ-
us studies have suggested that association,11,15,25,26 this is the ﬁrst
howing it with statistical robustness in the state of Rio Grande do
ul, where HIV-1C likely entered Brazil.
HIV-1C-infected patients showed higher CD4+ T-cell counts
ompared to other (non-C) variants. This observation could be
xplained by the more recent epidemic of HIV-1C in Brazil.20 This
ubtype, however, rapidly expanded in countries where it has been
ntroduced.34–36 An alternative explanation for this phenomenon
ay  rely on viral ﬁtness. CCR5-tropic HIV-1C has been shown to
arbor equivalent transmission ﬁtness to other HIV-1 group M sub-
ypes, but its virulence was  estimated some 100 times lower.37,38
he lower within-host pathogenicity displayed by HIV-1C might be
inked to a scenario where the host remains disease-free for a longer
ime, yet with similar transmission ability, leading to increased pro-
ortion over time in the population. Longitudinal studies in places
ith homogeneous populations infected by different HIV-1 sub-
ypes are required to elucidate this hypothesis.
In summary, this study showed a robust association between
IV-1C and heterosexual transmission within a population of
omogeneous demographic and ethnic characteristics. Southern
razil is an ideal locale for those studies, as relevant frequencies
f HIV-1C and B are seen. This area displays unique features that
llow the exclusion of confounding factors seen in most studies that
valuate HIV-1 subtype inﬂuence on disease progression.
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